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Background: The pathophysiology of recurrent pregnancy loss (RPL) is still unknown in 50% of the cases. Herein
we measure the expression of beta3 integrin subunit, a well-known implantation marker, in women with or without
RPL and correlate it with the histological dating of the endometrial tissue.
Methods: LH-timed endometrial biopsies were obtained from cases (RPL; n = 21, age 33.9+/−4.7) and healthy
controls (n = 29; age 29.8+/−4.1) during the mid-secretory phase (post ovulatory day: 8 to 10). Endometrial samples
were timed histologically according to Noyes’ criteria and underwent immunohistochemical staining for beta3
integrin expression. For statistical analysis the semi-quantitative HSCORE was assessed. Type I (beta3 negative in an
out-of-phase endometrium) and Type II defect (beta3 negative in an in-phase endometrium) were also analysed.
Statistical analysis was done with Student t-test, Mann Whitney U test, ANCOVA and chi square for trend. Significance
was set as P < 0.05.
Results: The mean (SD) age in controls was lower compared to cases [(29.8 (4.1) vs. 33.9 (4.7) – P = 0.001; Student
t-test)]. The median (range) expression of beta3 integrin in controls and cases was 1.94 (0 to 3.5) vs. 0.82 (0 to 3.6),
respectively (P = 0.001; Mann Whitney U test). Significance was still significant after adjusting for age (P = 0.03;ANCOVA).
The normal positive staining > =0.7 of beta3 integrin subunit and in-phase endometrium was seen in 24 out of 29
(82.8%) controls, but in only 6 out of 21 (28.6%) of cases with RPL; Type I and II defects were seen in 10.3 and 6.9%
of controls, while present in 52.4 and 19.1% of cases, respectively (P = 0.0005; chi-square).
Conclusions: Women with unexplained RPL had significantly reduced integrin expression compared to controls.
Our findings underline the need for further molecular analysis of endometrial tissue in affected women.
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Recurrent pregnancy loss (RPL), determined as two or
more consecutive abortions by some authors, are seen in
1-3% of couples; an underlying cause, however, is only
found in up to 50% [1]. These include embryonic factors,
like poor quality embryos with or without karyotype ab-
normalities, as well as maternal factors, such as uterine
malformations, general maternal infections, as well as
local inflammation [2], hormonal abnormalities, immuno-
genic abnormalities (like thyroid antibodies, cardiolipin* Correspondence: ariane.germeyer@med.uni-heidelberg.de
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unless otherwise stated.antibodies or antinuclear antibodies), genetic imbalances
and thrombophilic diseases [3].
However, when none of these factors are evident, the
recurrent pregnancy losses are classified as idiopathic,
because the underlying mechanisms are not well under-
stood. The functional expression of endometrial genes
and proteins have been examined, because they com-
promise the endometrial microenviroment and may
therefore contribute to an abnormal foetal-maternal
interaction, resulting in pregnancy failure [4]. Further-
more synchronisation between embryonic development
and endometrial decidualisation is found to be essential
for adequate implantation [5]. Many authors have stud-
ied the embryo-endometrium interface in order toral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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sion analysis [8,9] has determined the adequate endo-
metrial gene and protein expression during the short
endometrial receptive stage in the mid-secretory phase,
the so-called window of implantation (WOI) [10]. One
of these proteins is the αvβ3 integrin [11]. The com-
bined integrin αvβ3 acts as an adhesion promoter via
cell-cell interactions and it has been very well character-
ized within the human endometrium [12]. The αvβ3 in-
tegrin is expressed in the glandular epithelium during
the window of implantation and translocates into endo-
metrial stroma, if pregnancy occurs [13]. Reduced ex-
pression of αvβ3 has been related to unexplained
infertility [11] and in women with endometriosis [14].
Xu et al., in a recent publication, did not find any differ-
ence in β3 integrin expression in women with RPL com-
pared to normal fertile women [15]. However, these
authors analysed the expression of β3 integrin in forma-
lin fixed paraffin embedded (FFPE) samples. It is known
that β3 integrin expression in FFPE produces artefacts
and should be avoided [16]. In order to find a more ac-
curate expression of β3 integrin subunit in cases with
RPL, would be necessary to use frozen sections of endo-
metrial biopsies, instead of FFPE. Other authors re-
ported the expression of avβ3 integrin in endometrial-
frozen section and did not find any difference between
groups [17,18]. Contrary, other authors found a reduc-
tion of αvβ3 integrin during the implantation window in
patients with recurrent pregnancy loss, compared to
controls, either in frozen sections [19], or in microarray
studies [7]. Possible discrepancies among studies could
be related to technical differences. Our group has been
using the SSA6 antibody to identify the β3 integrin sub-
unit, and the expertise developed in our group to evalu-
ate β3 immunostaining has been validated using NIH
software image analysis [20]. This study has two objec-
tives: a) to examine the expression of the αvβ3 integrin
in women with RPL compared to healthy controls, b) toTable 1 Characteristics of the population
Characteristics Control n = 29
Age (y) mean (SD) 29.8 (4.1)
N. of miscarriage mean (SEM)
Endometrial dating
in/out-of-phase (n) 26/3
Defect typec n (%)
In phase with β3 + 24 (82.8)
Type I 3 (10.3)
Type II 2 (6.9)
aUnpaired Student t test.
bChi-square for trend.
cIn phase endometrium has positive β3 integrin subunit.
Type I defect is an out-of-phase endometrium and β3 integrin subunit expression is
Type II defect is an “in-phase” endometrium and β3 integrin subunit expression is ncompare integrin expression with morphologic dating of
the endometrium, which has been widely used to judge
the endometrial development and receptivity.
Methods
Samples collection and processing
This retrospective case–control study enrolled 21
women with identified unexplained RPL and 29 healthy
controls. Demographics are depicted in Table 1. Inclu-
sion criteria of “cases” were 2 or more pregnancy losses
in the presence of normal thyroid function, anticardioli-
pin antibodies, lupus anticoagulant and uterine anatomy.
Women with known uterine factors such as fibroids,
uterine septa or intrauterine synechia were excluded.
Other exclusion criteria were hormonal imbalance (ano-
vulation, polycystic ovary syndrome, diabetes or un-
treated thyroid disease) and known immunologic,
chromosomal or thrombophilic abnormalities. Controls
were obtained from regularly cycling, normal fertility
proven volunteers, without use of oral contraceptive in
the previous 3 months. Endometrial biopsies were ob-
tained from mid-secretory phase, 8–10 days after a urin-
ary LH surge. These biopsies were obtained in sterile
conditions, using a pipelle suction curettage at the out-
patient gynaecology clinic in Heidelberg, Germany and
in Chapel Hill, NC, USA. Endometrial biopsies were
divided into 2 portions: one was formalin fixed and
paraffin embedded for histological examination with
haematoxylin and eosin analysis (for endometrial dating)
and the other was frozen in liquid nitrogen for immuno-
histochemistry assessment of β3 subunit expression.
This study was submitted and approved by the Institu-
tional Review Boards of both institutions (Greenville
University Medical Center & University of Heidelberg).
Immunohistochemical staining
Immunostaining for β3 integrin subunit was performed
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CA) simultaneously in cases and controls in a same
batch. Diaminobenzidine (Sigma, St. Louis, MO)
was used as chromogen. All procedures were done sim-
ultaneously Tissue sections were fixed in 4% paraformal-
dehyde for 15 minutes. Following a rinse in PBS, pH 7.4,
endogenous peroxidase activity was quenched upon in-
cubation for 30 minutes with 0.3% H2O2 in absolute
methanol, followed by a 6-minute rehydration in phos-
phate buffered saline (PBS). Slides were then incubated
with 0.4% Triton-x 100 for 10 minutes. After incubation
with blocking serum for 30 minutes at room temperature
(4% normal goat serum), sections were incubated with
SSA6, a mouse monoclonal antibody against human β3 in-
tegrin subunit (1:2000). The specificity of this antibody
has been shown and confirmed by other authors [12,21].
Negative controls were analysed on adjacent sections in-
cubated without primary antibody. A PBS rinse was
followed by treatment with a secondary antibody consist-
ing of biotinylated goat anti-mouse IgG antibody for
30 minutes (Vector Laboratories). After this incubation,
sections were washed and incubated with avidin:biotinyl-
ated horseradish peroxidase macromolecular complex for
60 minutes. Diaminobenzidine (DAB) was added and in-
cubated for 8 minutes to complete the reaction and to
visualize the immunostaining. As a final step, sections
were counterstained with hematoxylin for 5 minutes,
dehydrated in a graded series of ethanols, and cleared with
xylene. A coverslip was placed over Permount for evalu-
ation by light microscopy. Negative external controls were
obtained by withholding the primary antibody and positive
internal controls were verified by the endometrial blood
vessel staining. The resulting staining was evaluated using
a Nikon microscope (Tokyo, Japan), by a single blinded
observer (B.A.L.) without knowledge of the subject’s
group. Board certified pathologists of both institutions
performed the endometrial dating according to Noyes’s
criteria [22]. Endometrial dating was considered as out-of-
phase, when a discrepancy of 3 days or more was seen be-
tween endometrial dating and date of the menstrual cycle.
Assessment of staining intensity and distribution in
endometrial glands was made using the semi-quantitative
histologic score (HSCORE) system. HSCORE was calcu-
lated using the following equation: HSCORE = ∑Pi (i + 1)/
100, where i = intensity of staining with a value of 1, 2,
or 3, (weak, moderate or strong, respectively) and Pi =
the percentage of stained endometrial epithelial cells for
each intensity, varying from 0-100%. Low intra-observer
(r = 0.983; P < 0.0001) and inter-observer (r = 0.994; P <
0.0001) differences for HSCORE in uterine tissues have
been previously reported using this technique [23]. The
numerical cut-off for a negative result for the αvβ3 in-
tegrin was a HSCORE of ≤ 0.7, based on previous ROC
analysis [21]. Based on histological dating, in-phase orout-of-phase, and β3 integrin expression, positive/nega-
tive, we proposed two types of defects: Type I defect is
an out-of-phase endometrium with negative β3 integrin
subunit expression, and Type II defect is an “in-phase”
endometrium with negative β3 integrin subunit expres-
sion [11].
Statistical analysis
Sample size was calculated using the same parameters as
previously published [24]; briefly, it was considered an α
and β error of 0.05 and 0.2, respectively; variance of the
expression of β3 integrin was considered as 0.79, and a
minimal difference of HSCORE between groups was 1.4,
i.e., the double of the 0.7 cut-off. These figures yielded,
at least, 7 cases per group. Gaussian distribution was
confirmed with D'Agostino & Pearson omnibus normal-
ity test. If Gaussian distribution was confirmed, unpaired
t-test was used; otherwise, it was used Mann–Whitney
U test. ANCOVA was used for adjusting HSCORE be-
tween groups, since age in controls and cases (recurrent
pregnancy loss) was significantly different. ANCOVA
online calculator (http://vassarstats.net/ancova2L.html)
and GraphPad Prism 6.0 (GraphPad Software, San Diego,
CA) were used for statistical analysis.
Results
Details of the population studied are depicted in Table 1.
HSCORE in controls was significantly higher compared
to the RPL group (Figure 1). The median (range) expres-
sion of β3 in controls and cases was 1.94 (0 to 3.5) vs.
0.82 (0 to 3.6), respectively (P = 0.001; Mann Whitney U
test). ANCOVA analysis was conducted to identify if age
between groups had influence on β3 subunit integrin ex-
pression. Levene’s test of equality of error variances was
0.7. After running ANCOVA analysis, age was adjusted,
and the P value between groups was 0.03, confirming
the significantly difference between groups, despite the
age difference between groups.
Morphological dating and comparison with integrin
staining
Compared to controls (n = 29), women with RPL (n =
21) showed more out-of-phase endometrium, i.e., histo-
logical delay in maturation. Only 10 out of 21 cases
(47.6 - 95 CI: 28.3 to 67.6%) were dated in-phase in RPL
samples. In contrast, 26 out 29 controls were in-phase
(89.7% - 95 CI: 73.6 to 96.4%). Likewise, positive expres-
sion of β3 integrin subunit followed the same pattern in
controls. Therefore positive expression of β3 integrin
subunit and an in-phase endometrium were present in
24 out of 29 controls (82.8% - 95 CI: 65.5 to 92.4%),
while only 6 out of 21 RPL (28.6% -95 CI: 13.8 to 50.0%)
samples could be considered “normal”. While a type II
defect, determined as in phase endometrium but negative
Figure 1 Immunohistochemistry. Representative
immunohistochemical expression of β3 integrin subunit during the
window of implantation in normal fertile women (A) and with
recurrent pregnancy loss (B). Note the negative expression of
integrin in luminal and glandular epithelium in B. Asterisk (*)
represents immunostaining for endometrial blood vessel, which is a
positive internal control magnification 200x. Individual values are
depicted in the graph (C) – Unpaired Student t test.
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trol samples (CI: 1.9 to 22.0%), 19.1% of RPL samples (CI:
7.7 to 40.0%) were affected (Table 1). The most frequent
defect seen in RPL samples (P = 0.0005) however was a
type I defect with 11 of 21 RPL samples (52.4% - 95 CI:
32.4 to 71.6%) compared to only 3 out of 29 controls
(10.3% - 95CI: 3.6 to 26.4%) (Table 1).
Discussion
The conflicting data on β3 integrin subunit expression
in endometrium of women with RPL led us to conduct
the present study. Our data indicate that women with
unexplained RPL have significantly reduced integrin ex-
pression compared to controls. Our results differ from
those published from Xu et al. [15] and Tuckerman [17].
The probable cause for this discrepancy is the method-
ology. As it is known, integrin is a membrane adhesion
protein and the use of FFPE technique yield artefacts
[16], or the variability between observers [17]. We have
shown that inexperienced observers in HSCORE tend to
give higher HSCOREs [20].
Despite the majority of cases from the RPL group
(0.52 – 95 CI: 0.32 to 0.71) demonstrated an out-of-
phase endometrium and a negative expression of integ-
rin β3 subunit (Type I defect), an additional 4 cases
[0.19 (95 CI:0.07 to 0.4)] presented a type II defect,where integrin expression is negative in an “in-phase”
endometrium. These findings demonstrate the need for
further molecular analysis, besides the histological as-
sessment of endometrial tissue. This finding is not new.
Coutifaris et al. suggested that morphological criteria do
not differ between fertile and infertile women [25]. Pos-
sible causes for this type II defect can be related to the
presence of endometriosis [26]. As endometriosis is as-
sociated with reduced integrin expression [21], a high-
unknown incidence of endometriosis in women with
recurrent abortions might be present, and the reduced
expression of integrin could be the first clue. This hypoth-
esis is supported by the findings that anti-lamin-1 anti-
body is reduced in women with endometriosis and with
recurrent pregnancy loss [27]. In light of recent evidence
linking endometriosis to progesterone resistance [28],
these findings support a possible connection between oc-
cult or undiagnosed gynaecologic pathology and a loss of
normal endometrial receptivity. The fact that integrin ex-
pression is reduced in RPL highlights the importance of
this adhesion protein for implantation. This reduction is
in accordance with other conditions related to infertility.
For instance, low integrin expression was seen in women
with different degrees of hydrosalpinges [24,29]. After re-
moval of hydrosalpinges, levels of αvb3 integrin increase
[30], as well as pregnancies rates [31].
The low expression of integrin in endometrium of
women with RPL supports the role of this adhesion mol-
ecule in the feto-maternal communication during im-
plantation. In patients with RPL, this reduction of integrin
expression may be due to the fact that HOXA10, another
implantation marker, regulates the expression of β3 integ-
rin [32]. HOXA10 has been shown to be a modulator of
integrin β3, and could be deregulated in endometrium of
women with RPL, as suggested by animal studies [33].
There are a few weaknesses in this study. Laparoscopy
was not routinely performed in these patients to investi-
gate peritoneal causes such as endometriosis. Likewise,
karyotyping was not performed, mainly because it has a
low yield for abnormalities (1 to 2%).
The appropriate statistical care, sample size and the
appropriate immunohistochemical analysis with a well-
established antibody are strengths of this study and cor-
roborate to the accuracy of the results.
Conclusions
In conclusion, we demonstrate that women with RPL
present an endometrial defect during the window of im-
plantation, more specifically, a reduced expression of β3
integrin subunit. Such defects comprised both “in-phase”
and “out-of-phase” histology. Further prospective studies
are needed to better determine the cause and treatment
of these types of endometrial receptivity defects in women
with otherwise unexplained RPL. If this correlation
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benefit from additional laparoscopic examination in order
to discover potential gynaecological conditions.
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